Share of the population living with HIV receiving antiretroviral therapy in Jamaica

Jamaica: Share of the population living with HIV receiving antiretroviral therapy was 54.1% in 2024. ◆ Volatile

Latest (2024)
54.1%
Change on year
up 2.4%
World rank
119th
of 149 countries
All-time high
54.1%
in 2024
All-time low
0.0%
in 1990
Years of data
35
1990–2024

Share of the population living with HIV receiving antiretroviral therapy in Jamaica, 1990–2024

02040601990200720241990: 0 %1991: 0 %1992: 0 %1993: 0 %1994: 0 %1995: 0 %1996: 0 %1997: 0 %1998: 0 %1999: 0 %2000: 0.018 %2001: 0.048 %2002: 0.174 %2003: 0.361 %2004: 0.617 %2005: 5.3 %2006: 6.7 %2007: 10.2 %2008: 12.8 %2009: 17.8 %2010: 19.9 %2011: 22.8 %2012: 25.7 %2013: 30.1 %2014: 32.7 %2015: 35 %2016: 38.3 %2017: 41.9 %2018: 44.7 %2019: 50 %2020: 46.1 %2021: 49.6 %2022: 52.1 %2023: 52.8 %2024: 54.1 %

Source: Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Measured in %.

Analysis

Jamaica recorded 54.1% for share of the population living with hiv receiving antiretroviral therapy in 2024. That is the highest value across all 35 years on record.

That represents a change of up 2.4% on the previous year and up 65.3% over ten years.

Over the whole period, share of the population living with hiv receiving antiretroviral therapy in Jamaica peaked at 54.1% in 2024 and was at its lowest, 0.0%, in 1990.

That places Jamaica 119th out of 149 countries with data for 2024, putting it in the bottom quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Share of the population living with HIV receiving antiretroviral therapy in Jamaica, year by year

Annual values for Share of the population living with HIV receiving antiretroviral therapy in Jamaica, 1990 to 2024.
Year % Change
1990 0.0% —
1991 0.0% —
1992 0.0% —
1993 0.0% —
1994 0.0% —
1995 0.0% —
1996 0.0% —
1997 0.0% —
1998 0.0% —
1999 0.0% —
2000 0.0% —
2001 0.0% +162.2%
2002 0.2% +263.9%
2003 0.4% +107.9%
2004 0.6% +71.1%
2005 5.3% +755.1%
2006 6.7% +27.4%
2007 10.2% +51.5%
2008 12.8% +26.0%
2009 17.8% +38.7%
2010 19.9% +12.1%
2011 22.8% +14.5%
2012 25.7% +12.5%
2013 30.1% +17.3%
2014 32.7% +8.5%
2015 35.0% +6.9%
2016 38.3% +9.5%
2017 41.9% +9.3%
2018 44.7% +6.7%
2019 50.0% +11.9%
2020 46.1% -7.7%
2021 49.6% +7.5%
2022 52.1% +5.0%
2023 52.8% +1.4%
2024 54.1% +2.4%

Jamaica compared with similar countries

  • Jamaica's 54.1% is below the median for upper middle income countries, which is 65.5%, 83% of the median. (43 countries reporting)
  • Jamaica's 54.1% is below the median for Latin America & Caribbean, which is 67.0%, 81% of the median. (29 countries reporting)

Biggest year-on-year movements

Years where Share of the population living with HIV receiving antiretroviral therapy in Jamaica changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2005 +755.1% 0.6% 5.3%
2002 +263.9% 0.0% 0.2%
2001 +162.2% 0.0% 0.0%
2003 +107.9% 0.2% 0.4%

Averages by decade

DecadeAverage LowestHighest Years
1990s 0.0% 0.0% 0.0% 10
2000s 5.4% 0.0% 17.8% 10
2010s 34.1% 19.9% 50.0% 10
2020s 50.9% 46.1% 54.1% 5

Countries ranked near Jamaica

  1. 116 Venezuela 56.6% compare
  2. 117 Bahrain 55.0% compare
  3. 118 Syria 54.8% compare
  4. 120 Moldova 53.0% compare
  5. 121 Kyrgyzstan 52.5% compare
  6. 122 Latvia 52.4% compare

See the full ranking of 149 places →

More reference data data for Jamaica

All data for Jamaica →

Frequently asked questions

What is share of the population living with hiv receiving antiretroviral therapy in Jamaica?
Share of the population living with hiv receiving antiretroviral therapy in Jamaica was 54.1% in 2024, according to Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data.
What is the highest share of the population living with hiv receiving antiretroviral therapy recorded in Jamaica?
The highest recorded value was 54.1% in 2024.
What is the lowest share of the population living with hiv receiving antiretroviral therapy recorded in Jamaica?
The lowest recorded value was 0.0% in 1990.
How does Jamaica rank for share of the population living with hiv receiving antiretroviral therapy?
Jamaica ranks 119th out of 149 countries with data for 2024.
Is share of the population living with hiv receiving antiretroviral therapy rising or falling in Jamaica?
Over the last ten years it is up 65.3%. The long-run trend across the full record is volatile.
Where does this Jamaica data come from?
The figures come from Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as part of Share of the population living with HIV receiving antiretroviral therapy. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 35 observations, free to reuse under CC BY 4.0 (Our World in Data).

Share, cite or embed this page

Cite this page

Share of the population living with HIV receiving antiretroviral therapy in Jamaica. Statizoid, drawing on Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Retrieved 29 September 2026, from https://reference.statizoid.com/stat/gap-to-reaching-the-target-of-art/jamaica/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://reference.statizoid.com/stat/gap-to-reaching-the-target-of-art/jamaica/">Share of the population living with HIV receiving antiretroviral therapy in Jamaica</a> — Statizoid

About this data

Indicator
Share of the population living with HIV receiving antiretroviral therapy
Unit
%
Source
Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
149 places, 5,062 data points, 1990–2024
Last refreshed

Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.